Kenvue Stock Plummets Amid Tylenol-Autism Controversy
21
2
BTCCSquare news:
Shares of Kenvue (KVUE), the Maker of Tylenol, tumbled more than 9% on Friday following a Wall Street Journal report linking the painkiller's use during pregnancy to autism. The report, attributed to Health Secretary Robert F. Kennedy Jr., suggests acetaminophen—Tylenol's active ingredient—could be a contributing factor. Kenvue maintains the FDA's decade-long research found no causal connection.
Market reaction was notably isolated to Kenvue, despite acetaminophen's widespread use in other over-the-counter drugs. The Department of Health and Human Services cautioned against premature conclusions, stating its ongoing investigation employs "gold-standard science" to address rising autism rates.
By:
